Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel D Kuns

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Blood|December 9, 2016
GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunityMark D Bunting, Antiopi Varelias, Fernando Souza-Fonseca-Guimaraes, et al.
Plos Pathogens|October 13, 2020
IL-27 signalling regulates glycolysis in Th1 cells to limit immunopathology during infectionMarcela Montes de Oca, Fabian de Labastida Rivera, Clay Winterford, et al.
Nature Medicine|December 1, 2011
Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host diseaseMotoko Koyama, Rachel D Kuns, Stuart D Olver, et al.
Blood|February 1, 2017
Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiomeAntiopi Varelias, Kate L Ormerod, Mark D Bunting, et al.
Blood|April 17, 2009
Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administrationRachel D Kuns, Edward S Morris, Kelli P A Macdonald, et al.
Blood|October 1, 2009
Soluble lymphotoxin is an important effector molecule in GVHD and GVLKate A Markey, Angela C Burman, Tatjana Banovic, et al.
The Journal of Clinical Investigation|October 10, 2018
Bone marrow transplantation generates T cell-dependent control of myeloma in miceSlavica Vuckovic, Simone A Minnie, David Smith, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 24, 2017
A critical role for donor-derived IL-22 in cutaneous chronic GVHDKate H Gartlan, Hemamalini Bommiasamy, Katelyn Paz, et al.
The Journal of Clinical Investigation|April 10, 2018
Recipient mucosal-associated invariant T cells control GVHD within the colonAntiopi Varelias, Mark D Bunting, Kate L Ormerod, et al.
The Journal of Clinical Investigation|August 27, 2014
CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host diseaseKylie A Alexander, Ryan Flynn, Katie E Lineburg, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Blood|December 9, 2016
GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunityMark D Bunting, Antiopi Varelias, Fernando Souza-Fonseca-Guimaraes, et al.
Plos Pathogens|October 13, 2020
IL-27 signalling regulates glycolysis in Th1 cells to limit immunopathology during infectionMarcela Montes de Oca, Fabian de Labastida Rivera, Clay Winterford, et al.
Nature Medicine|December 1, 2011
Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host diseaseMotoko Koyama, Rachel D Kuns, Stuart D Olver, et al.
Blood|February 1, 2017
Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiomeAntiopi Varelias, Kate L Ormerod, Mark D Bunting, et al.
Blood|April 17, 2009
Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administrationRachel D Kuns, Edward S Morris, Kelli P A Macdonald, et al.
Blood|October 1, 2009
Soluble lymphotoxin is an important effector molecule in GVHD and GVLKate A Markey, Angela C Burman, Tatjana Banovic, et al.
The Journal of Clinical Investigation|October 10, 2018
Bone marrow transplantation generates T cell-dependent control of myeloma in miceSlavica Vuckovic, Simone A Minnie, David Smith, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 24, 2017
A critical role for donor-derived IL-22 in cutaneous chronic GVHDKate H Gartlan, Hemamalini Bommiasamy, Katelyn Paz, et al.
The Journal of Clinical Investigation|April 10, 2018
Recipient mucosal-associated invariant T cells control GVHD within the colonAntiopi Varelias, Mark D Bunting, Kate L Ormerod, et al.
The Journal of Clinical Investigation|August 27, 2014
CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host diseaseKylie A Alexander, Ryan Flynn, Katie E Lineburg, et al.
Pageof 6